Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Silence Therapeutics Says Blood Cancer Trial Delivers 'Best-Case Outcome'
This $300 Million Biotech May Be Deeply Mispriced: Analyst
Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data
